And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, however, actually calls for a week off. And so, we plan to escort Mrs. Pharmalot and our shortest person on a round of adventures involving long-lost people, notable sites, and a dab of culture. And what about you? This is, of course, a wonderful time for a getaway if you have not already indulged. Or you may want to consider an excursion — beaches, lakes, and mountains are beckoning. Big cities often are more manageable as the natives escape for a spell, too. This is also an opportunity to check if your security clearance is still active. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon (although a colleague will fill in, so your morning tidbits will continue to arrive next week).
The Trump administration proposed that U.S. drug makers cut production quotas of the six most abused opioids by 10 percent next year to fight a nationwide addiction crisis, Reuters explains. The Justice Department and Drug Enforcement Administration say the proposed cut would be in keeping with President Trump’s effort to cut opioid prescription refills by one-third within three years. They plan to cut production quotas for oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine, and fentanyl by 7 percent to 15 percent, depending on the compound, in 2019.